Physiological Health Monitoring and Performance

SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.

IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.

Founded in 1960 by Dr. Joseph V. Brady, the Institutes for Behavior Resources, Inc. (IBR) is a nonprofit organization dedicated to enhancing the growth of behavioral sciences and their application to human affairs through research, clinical services, and educational initiatives. IBR focuses on addressing social challenges through innovative research and comprehensive health services.

LumenAstra, Inc. is at the forefront of developing innovative, wearable, non-invasive sensors for accurately measuring internal body temperatures. Originating from a need identified by DARPA to protect troops from heat stress, the company collaborates with the University of Colorado's Radio Frequency Lab to commercialize a patented technology. This technology, initially used for astronomical measurements, is now being adapted to monitor critical health parameters such as brain and tumor temperatures, promising to revolutionize medical monitoring and treatment.

Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.

Physical Sciences Inc. (PSI) is an employee-owned company dedicated to inventing, demonstrating, and translating technologies that address critical national needs in defense, security, healthcare, and environmental stewardship. With over 50 years of experience, PSI combines extensive research and development capabilities with a commitment to innovation and customer focus.

Massachusetts General Hospital (Mass General) is a world-renowned academic medical center and the original and largest teaching hospital of Harvard Medical School. Mass General is recognized for its commitment to high-quality patient care, innovative research, and comprehensive educational opportunities. The hospital operates the largest hospital-based research program in the United States, fostering collaboration among leading clinicians and scientists to bridge innovation science with state-of-the-art clinical medicine. Mass General for Children (MGfC) is a leader in pediatric care, offering more than 50 medical specialties and 15 surgical services, and is home to the only proton beam facility in New England. The hospital is dedicated to serving local and global communities, training the next generation of healthcare professionals, and advancing medical knowledge through groundbreaking research, multidisciplinary care, and a strong commitment to family-centered and equitable healthcare.

Lucid Reality Labs specializes in Extended Reality (XR) solutions enhanced by Artificial Intelligence (AI). Their iXR™ platform utilizes a unique Modular Architecture System to deliver personalized immersive experiences across various industries, focusing on exceptional visual fidelity and controlled environments. The company also offers a wide range of services in Augmented Reality (AR) and Mixed Reality (MR), catering to diverse sectors including healthcare, education, and enterprise solutions. With a commitment to responsible technology, Lucid Reality Labs aims to improve the quality of life globally through innovative XR applications.

The Medical Technology Enterprise Consortium (MTEC) is a 501(c)(3) charitable organization dedicated to advancing the rapid deployment of innovative medical technologies that improve the health of both military personnel and civilians. MTEC fosters military-civilian partnerships and collaboration among businesses, federal agencies, academic institutions, and other stakeholders. Through a flexible Other Transaction Agreement (OTA), MTEC expedites the development and commercialization of cutting-edge medical solutions, bridging the gap between research and real-world application. With over 700 members, MTEC has facilitated more than $1.3 billion in federal funding, 358 awarded projects, and a robust pipeline of 141 products.

Brimrose Technology Corporation (BTC) is dedicated to transforming promising new technologies into real products that enhance lives. With a strong focus on research and development, BTC collaborates with major U.S. agencies to create innovative solutions in various fields, including defense, medical diagnostics, and environmental applications. The company has a proven track record of securing significant funding and contracts, demonstrating its commitment to advancing technology for critical applications.

Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.

Vocxi Health is a diagnostic start-up focused on early disease detection through its innovative MyBreathPrint® system. This noninvasive technology allows for immediate health assessments by analyzing volatile organic compounds (VOCs) in a patient's breath, aiming to revolutionize patient care and improve health outcomes.

Ethos Solutions specializes in rapid problem solving in dynamic environments through the Ethos IDEALs (Identification, Define, Engagement, Alignment, and Leveraging). Ethos leverages module working groups (or cells) consisting of Subject Matter Expert (SMEs) clinicians, training cadre, warriors, academics, and researchers able to rapidly identify and solve problem sets that require a grounded approach forged in austere and dynamic environments.

Zeteo Tech is a venture-backed biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers. Their technology identifies airborne microbes, proteins, and lipids, enabling rapid screening for infectious diseases and bio-threats. With a focus on cost-effective solutions, Zeteo Tech aims to enhance biodefense capabilities and improve patient screening for diseases like tuberculosis.

CranioSense, Inc. is a clinical stage company focused on revolutionizing the measurement of intracranial pressure (ICP) with their innovative IPASS technology. This non-invasive solution aims to provide rapid and safe ICP assessments, addressing the critical need for better management of traumatic brain injury (TBI) and other conditions associated with elevated cranial pressure. By eliminating the need for invasive procedures, CranioSense is poised to significantly improve patient outcomes and healthcare practices.

The University of Chicago is a prestigious urban research university committed to rigorous inquiry and intellectual freedom. Founded in 1890, it has produced numerous Nobel laureates and is known for its transformative education and groundbreaking research across various fields. The university fosters an inclusive and diverse learning environment, encouraging participation from all community members.